Position in HALO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$27,317,794
+$14,955,433 QoQ
Shares Held
349,020
+82.5% QoQ
Ownership
0.308%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#68
of 667 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 72%
None 28%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,060,262,064 across 202 Biotechnology names. HALO ranks #27 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in HALO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,317,794 | 349,020 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $12,362,361 | 191,279 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $35,557,550 | 528,344 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $22,897,333 | 312,208 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $8,587,304 | 165,077 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $43,470,689 | 681,252 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $31,123,448 | 650,982 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $19,968,173 | 348,850 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $19,418,543 | 370,866 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $15,962,140 | 392,383 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $17,182,961 | 464,907 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $17,080,861 | 447,143 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $16,890,028 | 468,257 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $19,815,606 | 518,869 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $29,947,720 | 526,322 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $24,674,145 | 624,030 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $27,673,800 | 628,950 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $26,426,002 | 662,638 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $25,377,615 | 631,127 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $23,865,531 | 586,665 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $25,974,790 | 572,006 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $24,772,697 | 594,212 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $28,579,096 | 669,143 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $11,480,785 | 436,864 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $11,758,597 | 438,590 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,353,537 | 408,757 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||